EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms

Jaydeo T Kilbile, Suryakant B Sapkal, Gioele Renzi, Ilaria D'Agostino, Mohamed Boudjelal, Yasinalli Tamboli, Luigi Cutarella, Mattia Mori, Silvia Sgambellone, Serafina Villano, Silvia Marri, Laura Lucarini und 3 weitere

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Jaydeo T Kilbile und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Basic and Applied Sciences, MGM University, Chhatrapati Sambhajinagar, 431003, MS, India. Hauptthemen laut MEDLINE: Glaucoma, Carbonic Anhydrase Inhibitors, Sulfonamides, Piperazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah International Medical Research Center (KAIMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 2,4‐dichloro‐5‐{[4‐(phenylsulfonyl)piperazin‐1‐yl]carbonyl}benzenesulfonamides were designed and synthesized through amidation of Lasamide 1 with substituted piperazines. The newly obtained compounds demonstrated remarkable inhibition potency and selectivity for the human (h) expressed Carbonic Anhydrase (CA; EC 4.2.1.1) II isoform. Selected compounds 7 and 9 were investigated in an in vivo model of glaucoma and showed relevant performances, with the latter being able to last the effect up to 4 hours. The results herein reported are in sustainment of Lasamide derivatives as a new class of compounds potentially exploitable for the management of uncontrolled intra ocular pressure (IOP).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlaucomaCarbonic Anhydrase InhibitorsSulfonamidesPiperazinesHumansAnimalsStructure-Activity RelationshipCarbonic Anhydrase IIIntraocular PressureMolecular Structure

Stichwörter der Autor:innen

Carbonic AnhydraseGlaucomaIOPLasamideSulfonylpiperazines

Substanzen

Carbonic Anhydrase InhibitorsSulfonamidesPiperazinesCarbonic Anhydrase II

Autor:innen und Institutionen

  • Department of Chemistry, School of Basic and Applied Sciences, MGM University, Chhatrapati Sambhajinagar, 431003, MS, India.
  • NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, 50019, Sesto Fiorentino, Florence, Italy.
  • Department of Pharmacy, University of Pisa, 56126, Pisa, Italy.
  • Department of Pharmacy, University "G. d'Annunzio" Chieti-Pescara, 66100, Chieti, Italy.
  • King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, 14811, Saudi Arabia.
  • Department of Biotechnology, Chemistry and Pharmacy, University of Siena, via Aldo Moro 2, 53100, Siena, Italy.

Förderung

  • King Abdullah International Medical Research Center (KAIMRC)

Zitieren

APA

Kilbile, J. T., Sapkal, S. B., Renzi, G., D'Agostino, I., Boudjelal, M., Tamboli, Y., Cutarella, L., Mori, M., Sgambellone, S., Villano, S., Marri, S., Lucarini, L., Carradori, S., Carta, F., & Supuran, C. T. (2024). Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms. ChemMedChem. https://doi.org/10.1002/cmdc.202400601

Vancouver

Kilbile JT, Sapkal SB, Renzi G, D'Agostino I, Boudjelal M, Tamboli Y, et al. Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms. ChemMedChem. 2024. doi:10.1002/cmdc.202400601

BibTeX
@article{Kilbile2024,
  author = {Kilbile, Jaydeo T and Sapkal, Suryakant B and Renzi, Gioele and D'Agostino, Ilaria and Boudjelal, Mohamed and Tamboli, Yasinalli and Cutarella, Luigi and Mori, Mattia and Sgambellone, Silvia and Villano, Serafina and Marri, Silvia and Lucarini, Laura and Carradori, Simone and Carta, Fabrizio and Supuran, Claudiu T},
  title = {Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400601}
}
Kostenlos starten →